Figures
Abstract
Periodontitis is an inflammatory disease leading to the destruction of periodontal tissue. Vitamin D3 is an important hormone involved in the preservation of serum calcium and phosphate levels, regulation of bone metabolism and inflammatory response. Recent studies suggest that vitamin D3 metabolism might play a role in the progression of periodontitis. The aim of the present study was to examine the effects of 25(OH)D3, which is stable form of vitamin D3 in blood, and biologically active form 1,25(OH)2D3 on the production of interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemotactic protein-1 (MCP-1) by cells of periodontal ligament. Commercially available human periodontal ligament fibroblasts (hPdLF) and primary human periodontal ligament cells (hPdLC) were used. Cells were stimulated with either Porphyromonas gingivalis lipopolysaccharide (LPS) or heat-killed P. ginigvalis in the presence or in the absence of 25(OH)D3 or 1,25(OH)2D3 at concentrations of 10–100 nM. Stimulation of cells with either P. gingivalis LPS or heat-killed P. gingivalis resulted in a significant increase of the expression levels of IL-6, IL-8, and MCP-1 in gene as well as in protein levels, measured by qPCR and ELISA, respectively. The production of these pro-inflammatory mediators in hPdLF was significantly inhibited by both 25(OH)D3 and 1,25(OH)2D3 in a dose-dependent manner. In primary hPdLCs, both 25(OH)D3 and 1,25(OH)2D3 inhibited the production of IL-8 and MCP-1 but have no significant effect on the IL-6 production. The effect of both 25(OH)D3 and 1,25(OH)2D3 was abolished by specific knockdown of vitamin D3 receptor by siRNA. Our data suggest that vitamin D3 might play an important role in the modulation of periodontal inflammation via regulation of cytokine production by cells of periodontal ligament. Further studies are required for better understanding of the extents of this anti-inflammatory effect and its involvement in the progression of periodontal disease.
Citation: Andrukhov O, Andrukhova O, Hulan U, Tang Y, Bantleon H-P, Rausch-Fan X (2014) Both 25-Hydroxyvitamin-D3 and 1,25-Dihydroxyvitamin-D3 Reduces Inflammatory Response in Human Periodontal Ligament Cells. PLoS ONE 9(2): e90301. https://doi.org/10.1371/journal.pone.0090301
Editor: Makoto Makishima, Nihon University School of Medicine, Japan
Received: October 9, 2013; Accepted: January 31, 2014; Published: February 28, 2014
Copyright: © 2014 Andrukhov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by authors' institution (Bernhard Gottlieb School of Dentistry, Medical University of Vienna) and by International Team of Implantology Foundation (Project No. 781_2011). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Vitamin D3 is known to play an important role in the bone metabolism and mineral homeostasis [1]. The major sources of vitamin D3 in organism are production by skin on the sun exposure and dietary supplements. To become metabolically active, vitamin D3 is first converted by liver to 25(OH)D3 (calcifediol), which has a half life time of about 15 day [2]. Calcifideol could be further converted into the active form of vitamin D3 calcitriol (1,25(OH)2D3) by specific enzyme 25(OH)D-1α-hydroxylase. The half life time of 1,25(OH)2D3 is about 15 h [2] and its biological effects are mediated by activation of the vitamin D3 receptor (VDR), a member of the nuclear receptor superfamily [3]. For a long time it was thought that the expression of 1α-hydroxylase is limited to kidney, but now this enzyme is also found to be expressed in numerous extrarenal tissues [4]. There are accumulating evidences that vitamin D3 is also involved in the regulation of immune response [5].
Periodontitis is a chronic bacterial infectious disease that affects tooth supporting tissues of periodontium [6], [7]. Periodontitis is caused by overgrow of some anaerobic Gram-negative bacteria, which trigger host responses causing most of the tissue damages, and might lead to substantial loss of alveolar bone and eventually the loss of teeth [8]. Especially “red complex bacteria” that include the periodontal pathogens Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia have been strongly associated with clinical measurements of periodontitis [9]. The association between vitamin D3 and periodontitis is currently under investigation and its role in the progression of periodontitis is not entirely understood [10]. Some studies report decreased serum levels of vitamin D3 in periodontitis as well as a negative correlation between serum vitamin D3 levels and severity of periodontal inflammation [11], [12]. In contrast, other studies show the increased serum levels of vitamin D3 in patients with aggressive periodontitis and positive association between serum vitamin D3 concentration and periodontal disease severity [13], [14]. Thus, the role of vitamin D3 in periodontal disease needs to be further investigated.
Periodontal ligament is a structure connecting teeth to the alveolar bone and seems to actively participate in alveolar bone remodelling [15]. Periodontal ligament cells (PDLs) are fibroblast-like cells characterized by collagen production but also possessing some osteoblastic features (for review, see [16]). In addition, periodontal ligament cells produce several pro-inflammatory mediators when stimulated with Porphyromonas gingivalis and/or its components [16], [17], [18]. Periodontal ligament cells isolated from P. gingivalis-positive periodontitis patients exhibit increased cytokine production in response to P. gingivalis [19]. Due to the proximity of periodontal ligament to alveolar bone, the cytokine production by periodontal ligament cells might influence the processes of bone resorption in periodontal disease. Vitamin D3 might have an important role in the function of periodontal ligament in periodontal disease, because periodontal ligament cells express 1α-hydroxylase and convert 25(OH)D3 into 1,25(OH)2D3 [20], [21]. A recent study shows that 1,25(OH)2D3 inhibits production of interleukin-8 by primary human periodontal ligament cells but has no effect on production of IL-6 [22]. Yet, it is not known if 25(OH)D3, which is a biological precursor of 1,25(OH)2D3 and main form of vitamin D3 in blood, could also influence the inflammatory response in cells of human periodontal ligament.
The main aim of the present study was to investigate if 25(OH)D3 as well as 1,25(OH)2D3 influence the production of pro-inflammatory mediators in cells of human periodontal ligament in response to stimulation with periodontal pathogens. To answer this question we investigated the effect of 25(OH)D3 and 1,25(OH)2D3 on the production of interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemoattractant protein 1 (MCP-1) by cells of human periodontal ligament in response to stimulation with P. gingivalis LPS or heat-killed P. gingivalis. The contribution of VDR on the effect of both vitamin D3 forms was investigated in the experiments with deletion of this protein using small interfering RNA (siRNA).
In the present study, we use commercially available primary human periodontal ligament fibroblasts (hPdLF), which represent standardized model of periodontal ligament cells. In addition, the effect of both vitamin D3 forms was investigated on the primary human periodontal ligament cells (hPdLC) isolated from six different donors. Our results revealed that both 25(OH)D3 and 1,25(OH)2D3 might modulate periodontal inflammation via regulation of cytokine production by cells of periodontal ligament.
Materials And Methods
Ethic Statement
Protocol for primary human periodontal ligament cells isolation was approved by the Ethics Committee of the Medical University of Vienna. Patients were informed in details before the surgical procedures and gave their written agreement.
Cell Culture and reagents
Primary commercially available Clonetics human periodontal ligament fibroblasts (hPdLF) isolated from 16-year old male (Lonza, Switzerland) were used in the present study. These cells were shown to produce pro-inflammatory mediators and express osteogenesis-related genes, which is characteristic for periodontal ligament cells [23], [24], [25]. In addition, primary human periodontal ligament cells (hPdLC) were isolated from periodontally healthy donors undergoing routine extraction of their third molar teeth by outgrow method [26]. hPdLC were isolated by scraping the ligament tissue from the teeth root surface and cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (FBS), streptomycin (50 µg/ml) and penicillin (100 U/ml) under humidified air atmosphere of 5% CO2 at 37°C. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen), supplemented with 10% of FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified atmosphere containing 5% CO2. Cells from passage levels 3–6 were used in this study.
Commercially available ultrapure P. gingivalis LPS, heat-killed P. gingivalis, and ultrapure E. coli LPS (all from Invivogen, San Diego, USA) were used in the present study. As reported by other study [27], LPS preparations are free from contaminating lipoproteins.
Cells stimulation
Cells were seeded in a 24-well plate at a density of 5×104 cells per well containing 0.5 mL of DMEM medium supplemented with 10% FBS. After 24 h, cells were stimulated with either P. gingivalis LPS (1 µg/ml) or heat-killed P. gingivalis (108 cells/ml) in DMEM supplemented with 2% FBS. Stimulation was performed either in the presence or in the absence of 25(OH)D3 (10–100 nM, Cayman Chemicals, Ann Arbor, USA) or 1,25(OH)2D3 (10–100 nM, Sigma, San Diego, USA). Each experimental group included three wells. After stimulation for 24 h, the cellular mRNA expression levels of IL-6, IL-8 and MCP-1 in cells as well as the content of corresponding proteins in the conditioned media were determined.
Quantitative PCR
The mRNA expression levels of IL-6, IL-8, and MCP-1 were determined by qPCR as described previously [28], [29], taking the β-actin encoding gene as internal reference. Isolation of mRNA and transcription into cDNA was performed using the TaqMan Gene Expression Cells-to-CT kit (Ambion/Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. This kit provides good accuracy and superior sensitivity of gene-expression analysis [30]. qPCR was performed on an ABI StepOnePlus device (Applied Biosystems) in paired reactions using the Taqman gene expression assays with following ID numbers (all from Applied Biosystems): IL-6, Hs00985639_m1; IL-8, Hs00174103_m1; MCP-1, Hs00234140_m1; β-actin, Hs99999903_m1. qPCR reactions were performed in triplicate in 96-well plates using the following thermocycling conditions: 95°C for 10 min; 40 cycles, each for 15 s at 95°C and at 60°C for 1 min. The point at which the PCR product was first detected above a fixed threshold (cycle threshold, Ct), was determined for each sample. Changes in the expression of target genes were calculated using the 2−▵▵Ct method, where ▵▵Ct = (Cttarget−Ctβ−actin)sample−(Cttarget−Ctβ−actin)control, taking an untreated sample as a control.
Measurements of cytokines in supernatants
Commercially available ELISA kits (Hoelzel Diagnostika, Cologne, Germany) were used for measurements of IL-6, IL-8, and MCP-1 levels in the conditioned media. For measurement of IL-6 and MCP-1 samples were not diluted, whereas for measurements of IL-8 samples were diluted 1∶10.
RNA Interference of VDR
The highly specific technique of small interfering RNA (siRNA) was used to knockdown the expression of VDR in hPdLF. Cells were seeded at a density of 3×104 cells per well containing 0.5 mL of DMEM medium supplemented with 10% FBS without antibiotics. 24 h later, the cells were transfected with either VDR siRNA (Cat. Nr. Sc-106692, Santa Cruz Biotechnology, Heidelberg, Germany) or a non-silencing control siRNA (Cat. Nr. Sc-37007, Santa Cruz Biotechnology) using siRNA Reagent System (Cat. Nr. Sc-45064, Santa Cruz Biotechnology) according to the manufacturers protocol. 48 h after transfection, cells were stimulated by P. gingivalis LPS or heat-killed P. gingivalis in the presence or in the absence of 25(OH)D3 (100 nM) or 1,25(OH)2D3 (100 nM). Stimulation was performed in DMEM containing 2% of FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin. After 24 h, the gene expression levels of pro-inflammatory mediators IL-6, IL-8, and MCP-1 as well as the content of corresponding proteins in conditioned media were investigated. The effectivity of siRNA transfection was controlled by western blot. Protein samples were collected from cells, fractionated on SDS-PAGE and transferred to a nitrocellulose membrane. Immunoblots were incubated for 3 hours at room temperature with primary antibodies anti-VDR (Abcam) or anti-β-actin (Sigma). Then, membranes were incubated with anti-rabbit horseradish peroxidase-conjugated secondary antibodies (Amersham Life Sciences). Specific signal was visualized by ECL kit (Amersham Life Sciences). The protein bands (∼48 kDa for VDR and ∼42 kDa for β-actin, respectively) were quantified by Image Quant 5.0 software (Molecular Dynamics). Equal sample loading was confirmed by Ponceau S staining of the Western blot [31]. The expression levels were normalized to β-actin.
Statistical Analysis
The normal distribution of all data was tested with Kolmogorov-Smirnov test. After confirming normal distribution, the statistical differences between different groups were analysed by one-way analysis of variance (ANOVA) for repeated measures followed by t-test. All statistical analysis was performed using statistical program SPSS 19.0 (SPSS, Chicago, IL, USA). Data are expressed as mean ± S.E.M. Differences were considered to be statistically significant at p<0.05.
Results
Cytokine expression in hPdLF in response to stimulation with different concentrations of P. gingivalis LPS and heat-killed P. gingivalis
The response of hPdLF on the stimulation with different concentrations of P. gingivalis LPS (0.1–1 µg/ml) and heat-killed P. gingivalis (107–108 cells/ml) in comparison with that of well known pathogen E. coli LPS (1 µg/ml) is shown on the Figure 1. Gene expression levels of IL-6, IL-8, and MCP-1 significantly increased after stimulation with all stimuli. The increase in the expression levels of pro-inflammatory mediators in response to stimulation with 1 µg/ml of P. gingivalis LPS or 108 cells/ml of heat-killed P. gingivalis was similar (IL-6) or markedly higher (IL-8, MCP-1) in comparison with that to E. coli LPS. Therefore, these concentrations of P. gingivalis LPS and heat-killed P. gingivalis were used in our further experiments.
Cells were stimulated with E. coli LPS (1 µg/ml), P. gingivalis LPS (0.1–1 µg/ml), or heat-killed P. gingivalis (107–108 cells/ml) for 24 h. Gene expression levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured using q-PCR. Y-axes represent the n-fold expression levels of target gene in relation to non-stimulated cells (control).
Effect of vitamin D3 on the gene expression of pro-inflammatory mediators in hPdLF
The effect of 25(OH)D3 and 1,25(OH)2D3 on the gene expression levels of pro-inflammatory mediators IL-6, IL-8, and MCP-1 in hPdLF in response to stimulation with P. gingivalis LPS and heat-killed P. gingivalis is shown on the Figures 2 and 3, respectively. In commercially available cells, the expression levels of all pro-inflammatory mediators were significantly increased in response to stimulation with either P. gingivalis LPS or heat-killed P. gingivalis. Both 25(OH)D3 and 1,25(OH)2D3 at concentrations of 10–100 nM induced a dose-dependent decrease in the P. gingivalis LPS- and heat-killed P. gingivalis-induced gene-expression levels of IL-6, IL-8, and MCP-1 (p<0.05).
Cells were stimulated with P. gingivalis LPS (Pg LPS, 1 µg/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. Gene expression levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured using q-PCR. Y-axes represent the n-fold expression levels of target gene in relation to non-stimulated cells (control). # means significantly different from control group (2−▵▵Ct = 1). * means significantly different from cells stimulated with P. gingivalis LPS only.
Cells were stimulated with heat-killed P. gingivalis (hk Pg, 108 cells/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. Gene expression levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured using q-PCR. Y-axes represent the n-fold expression levels of target gene in relation to non-stimulated cells (control). # means significantly different from control group (2−δδCt = 1). * means significantly different from cells stimulated with heat-killed P. gingivalis only.
Effect of vitamin D3 on cytokines production by hPdLF in vitro
The effect of 25(OH)D3 and 1,25(OH)2D3 on the protein content of IL-6, IL-8, and MCP-1 in conditioned media after stimulation of hPdLF cells with P. gingivalis LPS and heat-killed P. gingivalis is shown on the Figures 4 and 5, respectively. The soluble protein levels of these pro-inflammatory mediators in conditioned media were significantly increased after stimulation with either P. gingivalis LPS (Figure 4) or heat-killed P. gingivalis (Figure 5). 25(OH)D3 and 1,25(OH)2D3 at concentrations of 10–100 nM induced dose-dependent decrease in the P. gingivalis LPS- and heat-killed P. gingivalis-induced production of IL-6, IL-8, and MCP-1.
Cells were stimulated with P. gingivalis LPS (Pg LPS, 1 µg/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. The levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured in cell supernatants using ELISA. # means significantly different from control group (non stimulated cells). * means significantly different from group stimulated with P.gingivalis LPS only
Cells were stimulated with heat-killed P. gingivalis (hk Pg, 108 cells/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. The levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured in cell supernatants using ELISA. # means significantly different from control group (non-stimulated cells). * means significantly different from group stimulated with heat-killed P.gingivalis only
Effect of vitamin D3 on expression of pro-inflammatory mediators in hPdLF transfected with either VDR siRNA or non-silencing control siRNA
Figure 5 shows the effect of expression of VDR protein in hPdLF after transfection with either VDR siRNA or control siRNA measured by Western blot. Transfection of hPdLF with VDR siRNA resulted in significant decrease of VDR protein expression. As measured by densitometry, transfected cells expressed about 20% of VDR protein compared to non-transfected cells. Transfection of hPdLF with control siRNA did not influence VDR expression. The effect of 25(OH)D3 and 1,25(OH)2D3 on the gene expression levels of pro-inflammatory mediators in response to stimulation with P. gingivalis LPS and heat-killed P. gingivalis in hPdLF transfected with VDR siRNA or control siRNA is shown on the Figures 6 and 7, respectively. The protein content of IL-6, IL-8, and MCP-1 in conditioned media is shown on the Figure 8. In hPdLF transfected with VDR siRNA neither 25(OH)D3 nor 1,25(OH)2D3 were able to diminish the response to P. gingivalis LPS or heat-killed P. gingivalis. This was true for both gene expression levels of IL-6, IL-8, and MCP-1 as well as for their content in conditioned media. In hPdLF transfected with control siRNA, both 25(OH)D3 and 1,25(OH)2D3 diminished the production of pro-inflammatory mediators in response to stimulation with P. gingivalis LPS or heat-killed P. gingivalis.
(A) Original western-blots of hPdLF. Protein samples were collected from cells, and the expression of VDR and β-actin was detected using specific antibodies. (B) Quantification of western blot analysis. The protein bands of VDR and β-actin were quantified by Image Quant 5.0 software (Molecular Dynamics). The expression levels were normalized to β-actin.
Gene expression levels of IL-6, IL-8, and MCP-1 were measured using q-PCR in hPdLF after transfection with either VDR siRNA or control siRNA and stimulation with P. gingivalis LPS (A, Pg LPS, 1 µg/ml) or heat-killed P. gingivalis (B, hk Pg, 108 cells/ml) in the presence or in the absence of 25(OH)D3 or 1,25(OH)2D3. Y-axes represent the n-fold expression levels of target gene in relation to non-stimulated cells. # means significantly different from control group (2−▵▵Ct = 1). * means significantly different from cells stimulated with heat-killed P. gingivalis LPS or heat-killed P. gingivalis only.
Cells were transfected with either VDR siRNA or control siRNA and stimulated with P. gingivalis LPS (Pg LPS, 1 µg/ml) or heat-killed P. gingivalis (hk Pg, 108 cells/ml) for 24 h in the presence or in the absence of 25(OH)D3 or 1,25(OH)2D3. # means significantly different from control group (2−▵▵Ct = 1). * means significantly different from cells stimulated with either P. gingivalis LPS or heat-killed P. gingivalis only
Effect of vitamin D3 on cytokines expression in primary hPdLC isolated from healthy individuals
The effect of 25(OH)D3 and 1,25(OH)2D3 on the gene expression levels of IL-6, IL-8, and MCP-1 in primary hPdLC after stimulation with P. gingivalis LPS and heat-killed P. gingivalis is shown on the Figure 9. The content of corresponding cytokines in the conditioned media is presented on the Figure 10. Similarly to hPdLF, in primary hPdLC, both 25(OH)D3 and 1,25(OH)2D3 induced a dose-dependent decrease in the P. gingivalis LPS- and heat-killed P. gingivalis-stimulated expression of IL-8 and MCP-1. Both forms of vitamin D3 tended to diminish IL-6 production by primary hPdLC but in contrast to hPdLF this effect was not statistically significant.
Cells were stimulated with P. gingivalis LPS (Pg LPS, 1 µg/ml) or heat-killed P. gingivalis (hk Pg, 108 cells/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. Gene expression levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured using q-PCR. Y-axes represent the n-fold expression levels of target gene in relation to non-stimulated cells (control). Data are presented as mean±SEM of six different donors. # means significantly different from control group (2−▵▵Ct = 1). * means significantly different from cells stimulated with P. gingivalis LPS or heat-killed P. gingivalis only.
Cells were stimulated with P. gingivalis LPS (Pg LPS, 1 µg/ml) or heat-killed P. gingivalis (hk Pg, 108 cells/ml) for 24 h in the presence or in the absence of different concentrations of 25(OH)D3 or 1,25(OH)2D3. The levels of IL-6 (A), IL-8 (B), and MCP-1 (C) were measured in cell supernatants using ELISA. # means significantly different from control group (non stimulated cells). * means significantly different from group stimulated with P.gingivalis LPS or heat-killed P. gingivalis only.
Discussion
In the present study we investigated the effect of two different forms of vitamin D3 25(OH)D3 and 1,25(OH)2D3, on the production of pro-inflammatory mediators by cells of human periodontal ligament in response to stimulation with P. gingivalis LPS or heat-killed P. gingivalis. We focused on the measurements of the expression of IL-6, IL-8, and MCP-1, which are produced by periodontal ligament cells and are thought to play an important role in the progression of periodontal disease. IL-6 is a pro-inflammatory cytokine, which plays a key role in acute inflammation phase and promotes bone resorption [32], [33]. IL-8 and MCP-1 are chemoattractant, which induce migration of neutrophils and monocytes, respectively, to the inflammation site and promote the development of acute inflammation [34], [35].
The main observation of the present study is that the production of pro-inflammatory cytokines by cells of periodontal ligament is inhibited by 25(OH)D3, which is the main form of vitamin D3 circulating in the blood and is commonly used for determination of vitamin D3 status. The effect of 25(OH)D3 was qualitatively similar to that of biologically active 1,25(OH)2D3. The optimal serum levels of 25(OH)D3 are thought to be about 70–100 nM [36] and these levels are similar to those used in our study. 25(OH)D3 is present in high amount in the gingival crevicular fluid, which is in direct proximity to periodontal ligament and its levels are increased in periodontal disease [14]. Therefore the effect of 25(OH)D3 on pro-inflammatory cytokine production observed in our study is physiologically relevant. Previous studies show that hPDLCs might locally convert vitamin D3 into 25(OH)D3 and subsequently into 1,25(OH)2D3 and the expression of enzyme responsible for this conversion is influenced by some pro-inflammatory mediators [20], [21]. Thus, on the one hand, the inflammatory response of periodontal ligament is regulated by both 25(OH)D3 and 1,25(OH)2D3 and, on the other hand, several factors involved in vitamin D3 metabolism are also regulated by inflammatory stimuli by feedback mechanisms. Vitamin D3 is also known to regulate osteogenic differentiation in periodontal ligament cells [37] and thus might affect the neighbouring alveolar bone. Therefore, it is plausible that vitamin D3 metabolism could play an important role in the regulation of the periodontal tissue homeostasis, especially during inflammation.
The exact physiological role of vitamin D3 effect on inflammatory response in periodontal ligament remains to be clarified. Decreased production of pro-inflammatory mediators by vitamin D3 might reduce the ability of immune system to recognize and eliminate pathogenic microorganisms on the one hand, but also could represent a protective mechanism prohibiting local excessive pro-inflammatory response and tissue destruction on the other hand [38]. Noteworthy, the effects of vitamin D3 in oral cavity are not associated only with decreased inflammatory response. Particularly, a study on human gingival epithelial cells shows that 1,25(OH)2D3 enhance immune response, which could lead to an increase in antibacterial activity against periodontal pathogens [39]. Periodontium is a complex tissue consisting by different cells types, which might participate in the host response to periodontal pathogens [40]. Thus, inflammatory response in various cells could be differently affected by vitamin D3 and this might influence the balance between bacterial elimination and tissue destruction during progression of periodontal disease. This assumption is made based on the observations of in vitro studies and further well-designed in vivo animal and/or clinical studies are required to understand the role of vitamin D3 in periodontitis. Since vitamin D3 influences inflammatory response in periodontal tissue, it might be considered as a potential tool for periodontal therapy. Some studies show that systemic vitamin D3 supplementation might have beneficial effect on periodontal health and periodontal therapy outcome [41], [42], [43]. Our data support the idea suggested by previous study[21], that topical application of vitamin D3, particularly 25(OH)D3, could be also considered as a potential tool in periodontal therapy.
We found that IL-6 production is inhibited by and 25(OH)D3 and 1,25(OH)2D3 in commercially available hPdLF but not in primary hPdLC. The reasons for this discrepancy between isolated primary hPdLC and commercially available hPdLF are not entirely clear. Interestingly, a previous study on primary hPdLC also shows that biologically active 1,25(OH)2D3 inhibits IL-8 production in response to stimulation with P. gingivalis, but has no effect on IL-6 production [22]. One of the possible explanations of this finding could be the methodological difference in the cell isolation protocol. In the present study, similarly to study of Tang et al, primary hPdLC were isolated by tissue outgrow method, whereas commercially available hPdLF were produced by supplier's Clonetics technique. Differences in periodontal ligament cells isolation methods are known to affect some cell properties [44]. Therefore it is possible that these changes also may lead to the modifications in cellular inflammatory responses observed in the present study. Moreover age and gender of the donor subjects may also contribute to the primary hPdLC properties [45], [46].
Our data showed that the action of both 25(OH)D3 and 1,25(OH)2D3 is mediated by VDR, because the silencing of this protein by specific siRNA resulted in abolishment of the effects of both forms of vitamin D. Therefore, regulation of expression levels of VDR in periodontal ligament cells might be important factor influencing functional properties of periodontal tissue. VDR is known to exhibit large polymorphism, which might contribute to different infectious disease [5], [47]. Previous clinical studies link VDR polymorphism to the chronic and aggressive periodontitis [48], [49], [50]. Therefore, the possibility that VDR polymorphism contributes to the regulation of inflammatory response by vitamin D3 in periodontal ligament cells cannot be excluded and requires further investigations.
Summarizing, our study shows that vitamin D3 modulates inflammatory response in periodontal ligament cells through vitamin D3 receptor. This finding suggests that both 1,25(OH)2D3 and 25(OH)D3 might affect inflammatory processes in periodontal disease. The exact role of vitamin D3 pathway in the progression of periodontal disease and possible therapeutic approaches in treatment or prophylaxis of periodontitis needs to be further investigated.
Acknowledgments
The authors acknowledge the help of Mrs. Phuong Quynh Nguyen and Mrs. Hedwig Rutschek (both Medical University of Vienna) for excellent technical assistance.
Author Contributions
Conceived and designed the experiments: O. Andrukhov O. Andrukhova XR-F. Performed the experiments: O. Andrukhov O. Andrukhova UH YT. Analyzed the data: O. Andrukhov O. Andrukhova UH YT XR-F. Contributed reagents/materials/analysis tools: O. Andrukhov H-PB XR-F. Wrote the paper: O. Andrukhov O. Andrukhova H-PB XR-F.
References
- 1. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92: 4–8.
- 2. Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88: 582S–586S.
- 3. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325–349.
- 4. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, et al. (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888–894.
- 5. White JH (2008) Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 76: 3837–3843.
- 6. Kinane DF (2001) Causation and pathogenesis of periodontal disease. Periodontol 2000 25: 8–20.
- 7. Holt SC, Ebersole JL (2005) Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”. a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 38: 72–122.
- 8. Genco RJ (1992) Host responses in periodontal diseases: current concepts. J Periodontol 63: 338–355.
- 9. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25: 134–144.
- 10.
Stein SH, Livada R, Tipton DA (2013) Re-evaluating the role of vitamin D in the periodontium. J Periodontal Res.
- 11. Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA (2004) Association between serum concentrations of 25–hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 80: 108–113.
- 12. Dietrich T, Nunn M, Dawson-Hughes B, Bischoff-Ferrari HA (2005) Association between serum concentrations of 25–hydroxyvitamin D and gingival inflammation. Am J Clin Nutr 82: 575–580.
- 13. Liu K, Meng H, Tang X, Xu L, Zhang L, et al. (2009) Elevated plasma calcifediol is associated with aggressive periodontitis. J Periodontol 80: 1114–1120.
- 14. Liu K, Meng H, Lu R, Xu L, Zhang L, et al. (2010) Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D(3) and interleukin-1beta in patients with aggressive periodontitis. J Periodontol 81: 260–266.
- 15. Beertsen W, McCulloch CA, Sodek J (1997) The periodontal ligament: a unique, multifunctional connective tissue. Periodontol 2000 13: 20–40.
- 16. Jonsson D, Nebel D, Bratthall G, Nilsson BO (2011) The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell. J Periodontal Res 46: 153–157.
- 17. Pathirana RD, O'Brien-Simpson NM, Reynolds EC (2010) Host immune responses to Porphyromonas gingivalis antigens. Periodontol 2000 52: 218–237.
- 18. Scheres N, Laine ML, de Vries TJ, Everts V, van Winkelhoff AJ (2010) Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. J Periodontal Res 45: 262–270.
- 19. Scheres N, Laine ML, Sipos PM, Bosch-Tijhof CJ, Crielaard W, et al. (2011) Periodontal ligament and gingival fibroblasts from periodontitis patients are more active in interaction with Porphyromonas gingivalis. J Periodontal Res 46: 407–416.
- 20. Liu K, Meng H, Hou J (2012) Activity of 25-hydroxylase in human gingival fibroblasts and periodontal ligament cells. PLoS ONE 7: e52053.
- 21. Liu K, Meng H, Hou J (2012) Characterization of the autocrine/paracrine function of vitamin D in human gingival fibroblasts and periodontal ligament cells. PLoS ONE 7: e39878.
- 22. Tang X, Pan Y, Zhao Y (2013) Vitamin D inhibits the expression of interleukin-8 in human periodontal ligament cells stimulated with Porphyromonas gingivalis. Arch Oral Biol 58: 397–407.
- 23. Jacobs C, Grimm S, Ziebart T, Walter C, Wehrbein H (2013) Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. Arch Oral Biol 58: 896–904.
- 24.
Jacobs C, Walter C, Ziebart T, Grimm S, Meila D, et al.. (2013) Induction of IL-6 and MMP-8 in human periodontal fibroblasts by static tensile strain. Clin Oral Investig.
- 25. Kumada Y, Zhang S (2010) Significant type I and type III collagen production from human periodontal ligament fibroblasts in 3D peptide scaffolds without extra growth factors. PLoS ONE 5: e10305.
- 26. Andrukhov O, Matejka M, Rausch-Fan X (2010) Effect of cyclosporin A on proliferation and differentiation of human periodontal ligament cells. Acta Odontol Scand 68: 329–334.
- 27. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S (2009) Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 88: 741–745.
- 28. Sekot G, Posch G, Messner P, Matejka M, Rausch-Fan X, et al. (2011) Potential of the Tannerella forsythia S-layer to delay the immune response. J Dent Res 90: 109–114.
- 29.
Andrukhov O, Ertlschweiger S, Moritz A, Bantleon HP, Rausch-Fan X (2013) Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts. Acta Odontol Scand.
- 30. Van Peer G, Mestdagh P, Vandesompele J (2012) Accurate RT-qPCR gene expression analysis on cell culture lysates. Sci Rep 2: 222.
- 31. Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, et al. (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318–320.
- 32. Fonseca JE, Santos MJ, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8: 538–542.
- 33. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, et al. (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 3297–3303.
- 34. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55: 97–179.
- 35. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86: 306–319.
- 36. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18–28.
- 37. Tang X, Meng H (2009) Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. Arch Oral Biol 54: 625–633.
- 38. Teng YT (2006) Protective and destructive immunity in the periodontium: Part 1—innate and humoral immunity and the periodontium. J Dent Res 85: 198–208.
- 39. McMahon L, Schwartz K, Yilmaz O, Brown E, Ryan LK, et al. (2011) Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun 79: 2250–2256.
- 40. Dixon DR, Bainbridge BW, Darveau RP (2004) Modulation of the innate immune response within the periodontium. Periodontol 2000 35: 53–74.
- 41. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, et al. (2011) The impact of vitamin D status on periodontal surgery outcomes. J Dent Res 90: 1007–1012.
- 42. Garcia MN, Hildebolt CF, Miley DD, Dixon DA, Couture RA, et al. (2011) One-year effects of vitamin D and calcium supplementation on chronic periodontitis. J Periodontol 82: 25–32.
- 43. Miley DD, Garcia MN, Hildebolt CF, Shannon WD, Couture RA, et al. (2009) Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis. J Periodontol 80: 1433–1439.
- 44. Tanaka K, Iwasaki K, Feghali KE, Komaki M, Ishikawa I, et al. (2011) Comparison of characteristics of periodontal ligament cells obtained from outgrowth and enzyme-digested culture methods. Arch Oral Biol 56: 380–388.
- 45. Shu L, Guan SM, Fu SM, Guo T, Cao M, et al. (2008) Estrogen modulates cytokine expression in human periodontal ligament cells. J Dent Res 87: 142–147.
- 46. Krieger E, Hornikel S, Wehrbein H (2013) Age-related changes of fibroblast density in the human periodontal ligament. Head Face Med 9: 22.
- 47. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143–156.
- 48. Martelli FS, Mengoni A, Martelli M, Rosati C, Fanti E (2011) VDR TaqI polymorphism is associated with chronic periodontitis in Italian population. Arch Oral Biol 56: 1494–1498.
- 49. Brett PM, Zygogianni P, Griffiths GS, Tomaz M, Parkar M, et al. (2005) Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 84: 1149–1153.
- 50. Tanaka K, Miyake Y, Hanioka T, Arakawa M (2013) VDR gene polymorphisms, interaction with smoking and risk of periodontal disease in Japanese women: the Kyushu Okinawa maternal and child health study. Scand J Immunol 78: 371–377.